Takayasu’s arteritis: A case report and a brief review of the literature
Abstract
Overview
Takayasu’s arteritis primarily affects young women. The current case report focuses
on a Caucasian middle-aged woman who complained of weakness, malaise, and fatigue for
as many as 19 years. Delayed diagnosis and lack of specific treatment could explain the extent
and the clinical severity of the disease at time of hospital admission. Angiography showed focal
narrowings of the abdominal and thoracic aorta and occlusion of both the subclavian arteries, of
the right coronary artery and severe stenosis of the first marginal obtuse. Takayasu’s arteritis is
not limited to women of Japanese origin but is present worldwide. Early diagnosis and treatment
is warranted. Outcome appears to be favorable when the disease is quiescent. (Heart International
2006; 2: 66-71)
Keywords
Takayasu’s arteritis, Inflammatory arteritis, Subclavian artery, Coronary artery
Article Information
Correspondence
Olivia Manfrini, MD, Dipartimento di Medicina Interna, Cardioangiologia, Epatologia, Alma Mater Studiorum University of Bologna, Via Massarenti, 9 (Padiglione 11), 40139 Bologna – Italy, olivia.manfrini@unibo.it
Further Resources
Trending Topic
Despite improved treatment of atherosclerotic cardiovascular disease, coronary artery disease (CAD) remains the leading cause of death and disability worldwide.1 Treatment of traditional risk factors, mainly low-density lipoprotein (LDL) cholesterol, is the foundation of atherosclerotic risk reduction. However, a considerable residual risk for cardiovascular disease (CVD) still exists despite reducing LDL cholesterol.2 Beyond traditional risk factors, other […]
Peripheral artery disease (PAD) is a severe manifestation of systemic atherosclerotic disease that commonly refers to lower-extremity arterial involvement. The global burden of PAD is estimated to involve over 200 million patients, with prevalence increasing by 24% over the past decade.1 In ...
There are several beneficial effects of statins on the progression of atherosclerosis, and there have been significant advancements in pharmacotherapies for atherosclerotic cardiovascular disease (ASCVD). However, substantial residual cardiovascular (CV) risk remains, and there is an unmet need to reduce ...
Cardiovascular disease (CVD) represents the prevailing cause of death in the United States.1 Cancer, accidents and other prevalent causes of death, have a multitude of pathophysiologic and mechanistic underpinnings leading to mortality. Meanwhile, the majority of CVD is primarily attributable ...
...
...
...
...
...
...
...
...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
